Evidence map›Paper›PMID 36104786›Full record

Observational studyBMC pulmonary medicine2022

Long-term follow-up of tuberculosis-destroyed lung patients after surgical treatment.

Hongyun Ruan, Fangchao Liu, Yunsong Li, Yuxuan Wang, Dongdong Hou, Xinting Yang, Bin Liu, Teng Ma, Zhidong Liu

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC pulmonary medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Value of preoperative evaluation of FEVBMC pulmonary medicine · 2024
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hongyun Ruan *Department of Cellular and Molecular Biology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, No 9, Bei guan Street, Tong Zhou District, Beijing, 101149, People's Republic of China.
Fangchao Liu *Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Science and Technology Office, Capital Medical University, Beijing, People's Republic of China.
Yunsong Li *Department of Thoracic Surgery, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, No 9, Bei guan Street, Tong Zhou District, Beijing, 101149, People's Republic of China.
Yuxuan Wang *Department of Thoracic Surgery, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, No 9, Bei guan Street, Tong Zhou District, Beijing, 101149, People's Republic of China.
Dongdong Hou *Department of Medical Oncology of Peking University Shougang Hospital, Beijing, People's Republic of China.
Xinting YangDepartment of Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
Bin LiuDepartment of Cellular and Molecular Biology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, No 9, Bei guan Street, Tong Zhou District, Beijing, 101149, People's Republic of China. liubin@ccmu.edu.cn.
Teng MaDepartment of Cellular and Molecular Biology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, No 9, Bei guan Street, Tong Zhou District, Beijing, 101149, People's Republic of China. mateng82913@163.com.
Zhidong LiuDepartment of Thoracic Surgery, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, No 9, Bei guan Street, Tong Zhou District, Beijing, 101149, People's Republic of China. liuzhidong0801@126.com.
Capital Medical University · CNBeijing Chest Hospital · CNPeking University Shougang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo monitor dypsnea and mortality at 5 and 10 years, respectively, after surgical treatment of tuberculosis-destroyed lung (TDL) patients.

methodsTDL patients treated surgically at Beijing Chest Hospital from November 2007 to June 2019 were monitored in this observational study. Follow-up assessments of respiratory function indicators and survival conducted 5 and 10 years post-surgery led to patient grouping based on mMRC score into a dyspnea group (mMRC ≥ 1) and a non-dyspnea group (mMRC = 0). Cox regression analysis detected effects of patient demographics, clinical characteristics, surgical factors and respiratory function on 5 year post-surgical survival.

resultsBy study completion (June 30, 2020), 32 of 104 patients were lost and 72 completed follow-up for a study total of 258.9 person-years. 45 patients (62.5%, 45/72) had mMRC scores of 0, while 12 (16.7%, 12/72), 21 (36.2%, 21/58) and 27 (60.0%, 27/45) patients exhibited dyspnea by 1, 3 and 5 years post-surgery, respectively. Low lung carbon monoxide diffusion score (DLCO% pred) and scoliosis contributed to dyspnea occurrence.

conclusionsMost TDL patients lacked subjective dyspnea signs post-surgery, while dyspnea rates increased with time. Preoperative low lung diffusion function and Scoliosis were associated with factors for postoperative dyspnea. Surgical treatment increased TDL patient survival overall.

Indexed as

ScoliosisTuberculosisDyspneaFollow-Up StudiesHumansLungDamaged lungLiving statusModified British medical research council (mMRC)Surgical treatmentTuberculosis

Identifiers

PMID36104786
PMCPMC9476694
OpenAlexW4295681902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.